Vanadium and proteins: Uptake, transport, structure, activity and function
暂无分享,去创建一个
João Costa Pessoa | Eugenio Garribba | E. Garribba | J. Pessoa | Marino F A Santos | T. Santos-Silva | Marino F.A. Santos | Teresa Santos-Silva | Marino F. A. Santos
[1] A. Sanz-Medel,et al. Biospeciation of various antidiabetic V(IV)O compounds in serum. , 2009, Dalton transactions.
[2] W. M. Huang,et al. An interlocked dimer of the protelomerase TelK distorts DNA structure for the formation of hairpin telomeres. , 2007, Molecular cell.
[3] Processive steps in the reverse direction require uncoupling of the lead head lever arm of myosin VI. , 2012, Molecular cell.
[4] P. Sadler,et al. Multi-metal binding site of serum albumin. , 1998, Journal of inorganic biochemistry.
[5] P. Pedersen,et al. Mitochondrial ATP Synthase , 2006, Journal of Biological Chemistry.
[6] D. Crans,et al. Trigonal Bipyramidal or Square Pyramidal Coordination Geometry? Investigating the Most Potent Geometry for Vanadium Phosphatase Inhibitors , 2014 .
[7] H. Dar,et al. Intermolecular phosphotransfer is crucial for efficient catalytic activity of nucleoside diphosphate kinase. , 2010, The Biochemical journal.
[8] Nicole M. Baker,et al. Structural studies of type I topoisomerases , 2008, Nucleic acids research.
[9] Hiroyuki Noji,et al. Rotation and structure of FoF1-ATP synthase. , 2011, Journal of biochemistry.
[10] K. Hodgson,et al. Characterization of isolated nitrogenase FeVco. , 2010, Journal of the American Chemical Society.
[11] B. Golden. Two distinct catalytic strategies in the hepatitis δ virus ribozyme cleavage reaction. , 2011, Biochemistry.
[12] Robert J.P. Williams,et al. The Natural Selection of the Chemical Elements: The Environment and Life's Chemistry , 1997 .
[13] T. Kiss,et al. A novel V(IV)O-pyrimidinone complex: synthesis, solution speciation and human serum protein binding. , 2013, Dalton transactions.
[14] Isabelle Bougie,et al. Inhibition of a metal-dependent viral RNA triphosphatase by decavanadate. , 2006, The Biochemical journal.
[15] Richard J. Kuhn,et al. Structure of the Flavivirus Helicase: Implications for Catalytic Activity, Protein Interactions, and Proteolytic Processing , 2005, Journal of Virology.
[16] Benjamin J Peters,et al. Vanadium–phosphatase complexes: Phosphatase inhibitors favor the trigonal bipyramidal transition state geometries , 2015 .
[17] S. Nehring,et al. Structural basis for DNA duplex separation by a superfamily-2 helicase , 2007, Nature Structural &Molecular Biology.
[18] M. Page,et al. Serine peptidases: Classification, structure and function , 2008, Cellular and Molecular Life Sciences.
[19] G. Micera,et al. On the prediction of 51V hyperfine coupling constants in V(IV)O complexes through DFT methods. , 2009, Dalton transactions.
[20] V. Guliants. Structure–reactivity relationships in oxidation of C4 hydrocarbons on supported vanadia catalysts , 1999 .
[21] Giovanni Micera,et al. Is the spin‐orbit coupling important in the prediction of the 51V hyperfine coupling constants of VIVO2+ species? ORCA versus Gaussian performance and biological applications , 2011, J. Comput. Chem..
[22] J. Champoux,et al. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures. , 2002, Journal of molecular biology.
[23] G. Murshudov,et al. Crystal structure of dodecameric vanadium-dependent bromoperoxidase from the red algae Corallina officinalis. , 2000, Journal of molecular biology.
[24] D. Singel,et al. Characterization of the ligand environment of vanadyl complexes of apoferritin by multifrequency electron spin-echo envelope modulation , 1991 .
[25] I. Bertini,et al. Spectral characterization of vanadium-transferrin systems. , 1985, Journal of inorganic biochemistry.
[26] A. Lange,et al. Bromoperoxidase activity of vanadate-substituted acid phosphatases from Shigella flexneri and Salmonella enterica ser. typhimurium. , 2002, European journal of biochemistry.
[27] The role of the C-terminal region in phosphoglycerate mutase. , 1999 .
[28] T. Kiss,et al. The speciation of vanadium in human serum , 2011 .
[29] L. Cantley,et al. The fate of cytoplasmic vanadium. Implications on (NA,K)-ATPase inhibition. , 1979, The Journal of biological chemistry.
[30] F. Marceau,et al. NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse. , 2010, Cardiovascular research.
[31] Alfonso Mondragón,et al. Emerging structural themes in large RNA molecules. , 2011, Current opinion in structural biology.
[32] P. Pedersen,et al. Ion motive ATPases. I. Ubiquity, properties, and significance to cell function , 1987 .
[33] W. Vogt,et al. Binding of vanadate to human albumin in infusion solutions, to proteins in human fresh frozen plasma, and to transferrin. , 2002, Journal of inorganic biochemistry.
[34] D. Fairlie,et al. Update 1 of: Proteases universally recognize beta strands in their active sites. , 2010, Chemical reviews.
[35] Susan M. Schelble,et al. Vanadate dimer and tetramer both inhibit glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides. , 1990, Biochemistry.
[36] Florian Odronitz,et al. Drawing the tree of eukaryotic life based on the analysis of 2,269 manually annotated myosins from 328 species , 2007, Genome Biology.
[37] E. Garman,et al. A complex iron-calcium cofactor catalyzing phosphotransfer chemistry , 2014, Science.
[38] J. McNeill,et al. Vanadium treatment of type 2 diabetes: a view to the future. , 2009, Journal of inorganic biochemistry.
[39] J. Champoux,et al. Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. , 1998, Science.
[40] C. Campa,et al. X-ray studies on ternary complexes of maltodextrin phosphorylase. , 2008, Archives of biochemistry and biophysics.
[41] R. Wever,et al. Kinetic characterization of active site mutants Ser402Ala and Phe397His of vanadium chloroperoxidase from the fungus Curvularia inaequalis , 2003 .
[42] T. Nakae,et al. Subunit structure of functional porin oligomers that form permeability channels in the other membrane of Escherichia coli. , 1979, The Journal of biological chemistry.
[43] T. Otake,et al. Discovery of a new vanadium accumulator, the fan wormPseudopotamilla occelata , 1993, Naturwissenschaften.
[44] J. Quinn,et al. Divergence of chemical function in the alkaline phosphatase superfamily: structure and mechanism of the P-C bond cleaving enzyme phosphonoacetate hydrolase. , 2011, Biochemistry.
[45] R. Crichton. Inorganic Biochemistry of Iron Metabolism: From Molecular Mechanisms to Clinical Consequences , 2001 .
[46] B. K. Hodnett. Vanadium-phosphorus Oxide Catalysts for the Selective Oxidation of C-4 Hydrocarbons To Maleic-anhydride , 1985 .
[47] M. Percival,et al. Inhibition of phosphoglucomutase by vanadate. , 1990, Biochemistry.
[48] R. Raines,et al. Value of general Acid-base catalysis to ribonuclease a. , 1994, Journal of the American Chemical Society.
[49] G. Micera,et al. Biotransformation of BMOV in the presence of blood serum proteins. , 2012, Metallomics : integrated biometal science.
[50] J. K. Grady,et al. Vanadium complexes of transferrin and ferritin in the rat. , 1986, Biochimica et biophysica acta.
[51] R. Sheldon,et al. Biocatalytic and biomimetic oxidations with vanadium. , 2000, Journal of inorganic biochemistry.
[52] V. Pecoraro,et al. Synthetic and computational modeling of the vanadium-dependent haloperoxidases , 2005 .
[53] W. R. Harris,et al. Thermodynamics of anion binding to human serum transferrin. , 1985, Biochemistry.
[54] R. Pratt,et al. Inhibition of serine amidohydrolases by complexes of vanadate with hydroxamic acids. , 2000, Biochemical and biophysical research communications.
[55] D. Manstein,et al. Inhibition of Myosin ATPase activity by halogenated pseudilins: a structure-activity study. , 2011, Journal of medicinal chemistry.
[56] L. Hedstrom. Serine protease mechanism and specificity. , 2002, Chemical reviews.
[57] G. F. Fuhrmann,et al. Effects of vanadate on intracellular reduction equivalents in mouse liver and the fate of vanadium in plasma, erythrocytes and liver. , 1984, Toxicology.
[58] H. Sakurai,et al. Binding constant of VIVO to transferrin , 2006 .
[59] Dagmar Ringe,et al. Inhibition of chymotrypsin by a complex of ortho-vanadate and benzohydroxamic acid: structure of the inert complex and its mechanistic interpretation. , 2007, Biochemistry.
[60] M. Dilworth,et al. Hydrazine is a product of dinitrogen reduction by the vanadium-nitrogenase from Azotobacter chroococcum. , 1991, The Biochemical journal.
[61] S. Rubinstein,et al. Remodeling of the Actin Cytoskeleton During Mammalian Sperm Capacitation and Acrosome Reaction1 , 2003, Biology of reproduction.
[62] António J. M. Ribeiro,et al. The catalytic mechanism of protein phosphatase 5 established by DFT calculations. , 2013, Chemistry.
[63] R. Rodenburg,et al. Mitochondrial ATP synthase: architecture, function and pathology , 2011, Journal of Inherited Metabolic Disease.
[64] James R. Williamson,et al. The catalytic diversity of RNAs , 2005, Nature Reviews Molecular Cell Biology.
[65] Wei Yang,et al. Crystal Structures of RNase H Bound to an RNA/DNA Hybrid: Substrate Specificity and Metal-Dependent Catalysis , 2005, Cell.
[66] L. Brunel,et al. High-Frequency Electron Paramagnetic Resonance Studies of VO2+ in Low-Temperature Glasses , 1999 .
[67] Wolfgang Jahnke,et al. Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein , 2008, The EMBO journal.
[68] A. Wlodawer,et al. Structure of phosphate-free ribonuclease A refined at 1.26 A. , 1988, Biochemistry.
[69] P. Myler,et al. An ensemble of structures of Burkholderia pseudomallei 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase , 2011, Acta crystallographica. Section F, Structural biology and crystallization communications.
[70] J. McGrath,et al. The purification and properties of phosphonoacetate hydrolase, a novel carbon-phosphorus bond-cleavage enzyme from Pseudomonas fluorescens 23F. , 1995, European journal of biochemistry.
[71] A. D. Gen,et al. A Horner-Wittig Synthesis of 1-Chlorovinyl Sulfoxides. , 1996 .
[72] Yilin Hu,et al. Extending the Carbon Chain: Hydrocarbon Formation Catalyzed by Vanadium/Molybdenum Nitrogenases , 2011, Science.
[73] R. Hamilton,et al. Human IgG subclass measurements in the clinical laboratory. , 1987, Clinical chemistry.
[74] Binding of VIVO2+ to the Fe binding sites of human serum transferrin. A theoretical study , 2013, JBIC Journal of Biological Inorganic Chemistry.
[75] Peter J Sadler,et al. Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. , 2008, Biochemical Society transactions.
[76] J. Littlechild,et al. Structural and functional comparisons between vanadium haloperoxidase and acid phosphatase enzymes , 2002, Journal of molecular recognition : JMR.
[77] M. Karin,et al. Mammalian MAP kinase signalling cascades , 2001, Nature.
[78] G. Yegutkin. Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. , 2008, Biochimica et biophysica acta.
[79] T. Ueki,et al. Vanadium-binding proteins (vanabins) from a vanadium-rich ascidian Ascidia sydneiensis samea. , 2003, Biochimica et biophysica acta.
[80] C. Rithner,et al. Application of time-resolved vanadium-51 2D NMR for quantitation of kinetic exchange pathways between vanadate monomer, dimer, tetramer, and pentamer , 1990 .
[81] G. C. Levy,et al. 51V-n.m.r. analysis of the binding of vanadium(V) oligoanions to sarcoplasmic reticulum. , 1985, The Biochemical journal.
[82] J. Iqbal,et al. Therapeutic Potentials of Ecto‐Nucleoside Triphosphate Diphosphohydrolase, Ecto‐Nucleotide Pyrophosphatase/Phosphodiesterase, Ecto‐5′‐Nucleotidase, and Alkaline Phosphatase Inhibitors , 2014, Medicinal research reviews.
[83] J. Quinn,et al. Cloning of the phosphonoacetate hydrolase gene from Pseudomonas fluorescens 23F encoding a new type of carbon-phosphorus bond cleaving enzyme and its expression in Escherichia coli and Pseudomonas putida. , 1997, Gene.
[84] N. Chasteen. The biochemistry of vanadium , 1983 .
[85] B. Foth,et al. New insights into myosin evolution and classification. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[86] M. Bangesh,et al. TD-DFT studies on the electronic structure of imidazole bound vanadate in vanadium containing haloperoxidases (VHPO) , 2005 .
[87] Kui Wang,et al. Membrane transport of vanadium compounds and the interaction with the erythrocyte membrane , 2003 .
[88] G. Mocz,et al. Vanadate Sensitized Photocleavage of Proteins , 1990 .
[89] A. Goldfine,et al. Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV). , 2001, Journal of inorganic biochemistry.
[90] J. Littlechild,et al. Enhancing effect of calcium and vanadium ions on thermal stability of bromoperoxidase from Corallina pilulifera , 2005, JBIC Journal of Biological Inorganic Chemistry.
[91] S. Macedo-Ribeiro,et al. X-ray crystal structures of active site mutants of the vanadium-containing chloroperoxidase from the fungus Curvularia inaequalis , 1999, JBIC Journal of Biological Inorganic Chemistry.
[92] T. Ueki,et al. Molecular mechanism of the transport and reduction pathway of vanadium in ascidians , 2011 .
[93] K. Föhr,et al. Characterization of the inositol 1,4,5-trisphosphate-induced calcium release from permeabilized endocrine cells and its inhibition by decavanadate and p-hydroxymercuribenzoate. , 1989, The Biochemical journal.
[94] P. Aisen,et al. Stoichiometric and site characteristics of the binding of iron to human transferrin. , 1978, The Journal of biological chemistry.
[95] I. Baranowska-Bosiacka,et al. Biochemical and medical importance of vanadium compounds. , 2012, Acta biochimica Polonica.
[96] D. Gefel,et al. Historic perspective and recent developments on the insulin-like actions of vanadium; toward developing vanadium-based drugs for diabetes , 2003 .
[97] K. Hodgson,et al. The uptake and fate of vanadyl ion in ascidian blood cells and a detailed hypothesis for the mechanism and location of biological vanadium reduction. A visible and X-ray absorption spectroscopic study. , 2008, Journal of inorganic biochemistry.
[98] S. Everse,et al. How the binding of human transferrin primes the transferrin receptor potentiating iron release at endosomal pH , 2011, Proceedings of the National Academy of Sciences.
[99] D. Rehder. Bioinorganic Vanadium Chemistry , 2008 .
[100] A. Casini,et al. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability. , 2011, Metallomics : integrated biometal science.
[101] T. Kunkel,et al. Aprataxin resolves adenylated RNA-DNA junctions to maintain genome integrity , 2013, Nature.
[102] D. Dunaway-Mariano,et al. The catalytic scaffold of the haloalkanoic acid dehalogenase enzyme superfamily acts as a mold for the trigonal bipyramidal transition state , 2008, Proceedings of the National Academy of Sciences.
[103] P. Pedersen,et al. Chemical Mechanism of ATP Synthase , 1999, The Journal of Biological Chemistry.
[104] G. Micera,et al. Uptake of potential anti-diabetic VIVO compounds of picolinate ligands by red blood cells , 2014 .
[105] J. Champoux. DNA topoisomerases: structure, function, and mechanism. , 2001, Annual review of biochemistry.
[106] J. Dixon,et al. Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[107] Timothy D. Fenn,et al. Structural and functional comparisons of nucleotide pyrophosphatase/phosphodiesterase and alkaline phosphatase: implications for mechanism and evolution. , 2006, Biochemistry.
[108] J. Janin,et al. Three-Dimensional Structure of Nucleoside Diphosphate Kinase , 2000, Journal of bioenergetics and biomembranes.
[109] Yilin Hu,et al. Radical SAM-Dependent Carbon Insertion into the Nitrogenase M-Cluster , 2012, Science.
[110] H. Akiyama,et al. Binding patterns of vanadium to transferrin in healthy human serum studied with HPLC/high resolution ICP-MS. , 2004, The Analyst.
[111] V. Müller,et al. ATP synthases from archaea: the beauty of a molecular motor. , 2014, Biochimica et biophysica acta.
[112] W. Casey,et al. Sarcoplasmic reticulum calcium ATPase interactions with decaniobate, decavanadate, vanadate, tungstate and molybdate. , 2012, Journal of inorganic biochemistry.
[113] Michael G. Davis,et al. Mechanism of insulin sensitization by BMOV (bis maltolato oxo vanadium); unliganded vanadium (VO4) as the active component. , 2003, Journal of inorganic biochemistry.
[114] Sean J. Johnson,et al. Insights into the Reaction of Protein-tyrosine Phosphatase 1B , 2010, The Journal of Biological Chemistry.
[115] Hiromu Sakurai,et al. Antidiabetic vanadium(IV) and zinc(II) complexes , 2002 .
[116] V. Van Hoof,et al. Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns. , 1994, Critical reviews in clinical laboratory sciences.
[117] C. W. Peterson,et al. On the evolutionary significance and metal-binding characteristics of a monolobal transferrin from Ciona intestinalis , 2008, Proceedings of the National Academy of Sciences.
[118] D A Winkelmann,et al. Three-dimensional structure of myosin subfragment-1: a molecular motor. , 1993, Science.
[119] Irini Akritopoulou-Zanze,et al. Kinase-targeted libraries: the design and synthesis of novel, potent, and selective kinase inhibitors. , 2009, Drug discovery today.
[120] H. Yokosawa,et al. Isolation, characterization and cDNA cloning of a one-lobed transferrin from the ascidian Halocynthia roretzi. , 2001, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[121] W. M. Huang,et al. An Enzyme-Catalyzed Multistep DNA Refolding Mechanism in Hairpin Telomere Formation , 2013, PLoS biology.
[122] S. West,et al. Molecular Mechanism of DNA Deadenylation by the Neurological Disease Protein Aprataxin* , 2008, Journal of Biological Chemistry.
[123] G. Gilliland,et al. X-ray structure of a ribonuclease A-uridine vanadate complex at 1.3 A resolution. , 1997, Acta crystallographica. Section D, Biological crystallography.
[124] Hiromu Sakurai,et al. Current state for the development of metallopharmaceutics and anti-diabetic metal complexes. , 2008, Chemical Society reviews.
[125] N. Sträter,et al. Crystallographic snapshots along the reaction pathway of nucleoside triphosphate diphosphohydrolases. , 2013, Structure.
[126] H. Sakurai,et al. Pharmacokinetic study and trial for preparation of enteric-coated capsule containing insulinomimetic vanadyl compounds: implications for clinical use. , 2003, Mini reviews in medicinal chemistry.
[127] W. Brill,et al. Isolation of an iron-molybdenum cofactor from nitrogenase. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[128] Marcos A. Villarreal,et al. Vanadate inhibits the ATPase activity and DNA binding capability of bacterial MutS. A structural model for the vanadate-MutS interaction at the Walker A motif. , 2002, Nucleic acids research.
[129] Z. Sauna,et al. Functionally Similar Vanadate-induced 8-Azidoadenosine 5′-[α-32P]Diphosphate-trapped Transition State Intermediates of Human P-glycoprotein Are Generated in the Absence and Presence of ATP Hydrolysis* , 2001, The Journal of Biological Chemistry.
[130] K. Rubinson,et al. The transport and accumulation of oxyvanadium compounds in human erythrocytes in vitro. , 1982, The Journal of laboratory and clinical medicine.
[131] C. Kimblin,et al. Modeling the catalytic site of vanadium bromoperoxidase: synthesis and structural characterization of intramolecularly H-bonded vanadium(V) oxoperoxo complexes, [VO(O(2))((NH)2pyg(2))]K and [VO(O(2))((BrNH)2pyg(2))]K. , 2002, Inorganic chemistry.
[132] Jaqueline D. Hooker,et al. Inhibition of acid, alkaline, and tyrosine (PTP1B) phosphatases by novel vanadium complexes. , 2010, Journal of inorganic biochemistry.
[133] M. A. Nesmeyanova,et al. Phosphonates and Their Degradation by Microorganisms , 2002, Biochemistry (Moscow).
[134] C. Carrano,et al. Binding of vanadate to human serum transferrin. , 1984, Journal of inorganic biochemistry.
[135] H. Vogel,et al. Metal-ion binding properties of the transferrins: a vanadium-51 NMR study. , 1996, Journal of inorganic biochemistry.
[136] Karen N. Allen,et al. Structure-Function Analysis of 2-Keto-3-deoxy-D-glycero-D-galactonononate-9-phosphate Phosphatase Defines Specificity Elements in Type C0 Haloalkanoate Dehalogenase Family Members* , 2009, Journal of Biological Chemistry.
[137] J. Moura,et al. Recent advances into vanadyl, vanadate and decavanadate interactions with actin. , 2012, Metallomics : integrated biometal science.
[138] J. Pessoa. Thirty years through vanadium chemistry. , 2015 .
[139] K. Kustin,et al. Vanadium : a biologically relevant element , 1990 .
[140] R. Wever,et al. A new model for the membrane topology of glucose‐6‐phosphatase: the enzyme involved in von Gierke disease , 1997, FEBS letters.
[141] M. Newcomer,et al. Crystal Structure of Fosfomycin Resistance Kinase FomA from Streptomyces wedmorensis* , 2008, Journal of Biological Chemistry.
[142] K. Williams,et al. The determination of dissolved and particulate vanadium in sea water by x-ray fluorescence spectrometry , 1983 .
[143] F. Quiocho,et al. Trapping the transition state of an ATP-binding cassette transporter: evidence for a concerted mechanism of maltose transport. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[144] Thomas A. Richards,et al. Evolution and Classification of Myosins, a Paneukaryotic Whole-Genome Approach , 2014, Genome biology and evolution.
[145] J. Montreuil,et al. Comparative study of the iron-binding properties of human transferrins. II. Electron paramagnetic resonance of mixed metal complexes of human lactotransferrin. , 1983, Biochimica et Biophysica Acta.
[146] Katherine H Thompson,et al. Vanadium in diabetes: 100 years from Phase 0 to Phase I. , 2006, Journal of inorganic biochemistry.
[147] Subhash G. Vasudevan,et al. Structure of the Dengue Virus Helicase/Nucleoside Triphosphatase Catalytic Domain at a Resolution of 2.4 Å , 2005, Journal of Virology.
[148] M. Aureliano,et al. Decavanadate in vitro and in vivo effects: facts and opinions. , 2014, Journal of inorganic biochemistry.
[149] G. Micera,et al. Interaction of antidiabetic vanadium compounds with hemoglobin and red blood cells and their distribution between plasma and erythrocytes. , 2014, Inorganic chemistry.
[150] E. E. Kim,et al. Reaction mechanism of alkaline phosphatase based on crystal structures. Two-metal ion catalysis. , 1991, Journal of molecular biology.
[151] M. Fedor,et al. Structure and function of the hairpin ribozyme. , 2000, Journal of molecular biology.
[152] G. Micera,et al. Interaction of VO2+ ion with human serum transferrin and albumin. , 2009, Journal of inorganic biochemistry.
[153] M. J. Jedrzejas,et al. Structure, function, and evolution of phosphoglycerate mutases: comparison with fructose-2,6-bisphosphatase, acid phosphatase, and alkaline phosphatase. , 2000, Progress in biophysics and molecular biology.
[154] M. Aureliano,et al. Decavanadate effects in biological systems. , 2005, Journal of inorganic biochemistry.
[155] J. Hartung,et al. Parameters for bromination of pyrroles in bromoperoxidase-catalyzed oxidations , 2011 .
[156] Douglas C. Rees,et al. The E. coli BtuCD Structure: A Framework for ABC Transporter Architecture and Mechanism , 2002, Science.
[157] I. G. Fantus,et al. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. , 1994, The Journal of biological chemistry.
[158] J. Vincent,et al. Low pH binding of vanadyl to bovine lactoferrin , 1979, FEBS letters.
[159] Katherine H Thompson,et al. Metal complexes in medicinal chemistry: new vistas and challenges in drug design. , 2006, Dalton transactions.
[160] M. Fedor. Comparative enzymology and structural biology of RNA self-cleavage. , 2009, Annual review of biophysics.
[161] K. Schwarz,et al. Growth Effects of Vanadium in the Rat , 1971, Science.
[162] D. Fattorini,et al. Hyper-Accumulation of Vanadium in Polychaetes , 2012 .
[163] T. Maitani,et al. Binding patterns of vanadium ions with different valence states to human serum transferrin studied by HPLC/high-resolution ICP-MS. , 2002, Biochemical and biophysical research communications.
[164] A. Burgin,et al. A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[165] J. Tainer,et al. Crystal structure of the human cell cycle protein CksHs1: single domain fold with similarity to kinase N-lobe domain. , 1995, Journal of molecular biology.
[166] A. Tracey,et al. Vanadium(V) oxyanions: the interaction of vanadate with pyrophosphate, phosphate, and arsenate , 1986 .
[167] N. Sträter,et al. Structural insight into signal conversion and inactivation by NTPDase2 in purinergic signaling , 2008, Proceedings of the National Academy of Sciences.
[168] J. Rodrigues,et al. Unveiling the Interaction of Vanadium Compounds with Human Serum Albumin by Using 1H STD NMR and Computational Docking Studies , 2013 .
[169] G. Micera,et al. Binding of Oxovanadium(IV) to Tripeptides Containing Histidine and Cysteine Residues and Its Biological Implication in the Transport of Vanadium and Insulin‐Mimetic Compounds , 2005 .
[170] D. Barford,et al. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. , 1995, Science.
[171] K. Brew,et al. The primary structure of human serum transferrin. The structures of seven cyanogen bromide fragments and the assembly of the complete structure. , 1983, The Journal of biological chemistry.
[172] L. Pedersen,et al. Crystal structure of estrogen sulphotransferase , 1997, Nature Structural Biology.
[173] D. Rehder. Is vanadium a more versatile target in the activity of primordial life forms than hitherto anticipated? , 2008, Organic & biomolecular chemistry.
[174] N. Chasteen. Human serotransferrin: structure and function , 1977 .
[175] D. Crans,et al. Decavanadate (V10 O28 6-) and oxovanadates: oxometalates with many biological activities. , 2009, Journal of inorganic biochemistry.
[176] E. Tajkhorshid,et al. Structural basis for iron piracy by pathogenic Neisseria , 2012, Nature.
[177] D. Gambino. Potentiality of vanadium compounds as anti-parasitic agents , 2011 .
[178] H. Michibata,et al. Isolation of highly acidic and vanadium-containing blood cells from among several types of blood cell from Ascidiidae species by density-gradient centrifugation , 1991 .
[179] D. Schomburg,et al. X-ray structure determination of a vanadium-dependent haloperoxidase from Ascophyllum nodosum at 2.0 A resolution. , 1999, Journal of molecular biology.
[180] G. Grüber,et al. The transition-like state and Pi entrance into the catalytic a subunit of the biological engine A-ATP synthase. , 2011, Journal of molecular biology.
[181] T. Kiss,et al. Evaluation of the binding of oxovanadium(IV) to human serum albumin. , 2012, Dalton transactions.
[182] J. Hartung,et al. Bromoperoxidases and functional enzyme mimics as catalysts for oxidative bromination—A sustainable synthetic approach , 2011 .
[183] K. Peters,et al. Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery. , 2006, Acta crystallographica. Section D, Biological crystallography.
[184] S. Yokoyama,et al. Solution structure of Vanabin2, a vanadium(IV)-binding protein from the vanadium-rich ascidian Ascidia sydneiensis samea. , 2005, Journal of the American Chemical Society.
[185] João Costa Pessoa,et al. Vanadium Complexes as Prospective Therapeutics: Structural Characterization of a V(Iv) Lysozyme Adduct , 2014 .
[186] M. Newcomer,et al. Structural and biochemical insights into the mechanism of fosfomycin phosphorylation by fosfomycin resistance kinase FomA. , 2011, Biochemistry.
[187] B. Brenner,et al. The mechanism of pentabromopseudilin inhibition of myosin motor activity , 2009, Nature Structural &Molecular Biology.
[188] S. Baserga,et al. The long unwinding road of RNA helicases. , 2007, Molecular cell.
[189] K. Föhr,et al. Decavanadate displaces inositol 1,4,5-trisphosphate (IP3) from its receptor and inhibits IP3 induced Ca2+ release in permeabilized pancreatic acinar cells. , 1991, Cell calcium.
[190] H. Delves,et al. Distribution of zinc amongst human serum globulins determined by gel filtration--affinity chromatography and atomic-absorption spectrophotometry. , 1984, The Analyst.
[191] D. Crans,et al. Interaction of rabbit muscle aldolase at high ionic strengths with vanadate and other oxoanions. , 1992, Biochemistry.
[192] M. Hir. A soluble 5'-nucleotidase in rat kidney. Stimulation by decavanadate. , 1991 .
[193] D. Crans,et al. Nonreductive interaction of vanadate with an enzyme containing a thiol group in the active site: glycerol-3-phosphate dehydrogenase. , 1991, Biochemistry.
[194] Lisa A. Lambert,et al. Molecular Evolution of the Transferrin Receptor/Glutamate Carboxypeptidase II Family , 2006, Journal of Molecular Evolution.
[195] A Wlodawer,et al. Nuclear magnetic resonance and neutron diffraction studies of the complex of ribonuclease A with uridine vanadate, a transition-state analogue. , 1985, Biochemistry.
[196] B. Gopal,et al. Conformational basis for substrate recruitment in protein tyrosine phosphatase 10D. , 2011, Biochemistry.
[197] W. R. Harris,et al. Equilibrium model for speciation of aluminum in serum. , 1992, Clinical chemistry.
[198] J. Wedekind,et al. Base ionization and ligand binding: how small ribozymes and riboswitches gain a foothold in a protein world. , 2011, Current opinion in structural biology.
[199] Daniel Herschlag,et al. Biological phosphoryl-transfer reactions: understanding mechanism and catalysis. , 2011, Annual review of biochemistry.
[200] W. Plass. Chiral and supramolecular model complexes for vanadium haloperoxidases: Host–guest systems and hydrogen bonding relays for vanadate species , 2011 .
[201] I. Gibbons,et al. Specific cleavage of dynein heavy chains by ultraviolet irradiation in the presence of ATP and vanadate. , 1986, The Journal of biological chemistry.
[202] P. Aisen,et al. Iron binding to horse spleen apoferritin: a vanadyl ENDOR spin probe study. , 1991, Biochemistry.
[203] D. Lilley,et al. Structure, folding and mechanisms of ribozymes. , 2005, Current opinion in structural biology.
[204] Ivan Rayment,et al. X-ray structure of the magnesium(II).ADP.vanadate complex of the Dictyostelium discoideum myosin motor domain to 1.9 A resolution. , 1996 .
[205] A. Guskov,et al. Structural diversity of ABC transporters , 2014, The Journal of general physiology.
[206] Application of DFT methods to the study of the coordination environment of the VO2+ ion in V proteins , 2012, JBIC Journal of Biological Inorganic Chemistry.
[207] K. Gekko,et al. A novel vanadium reductase, Vanabin2, forms a possible cascade involved in electron transfer. , 2009, Biochimica et biophysica acta.
[208] G. Micera,et al. A quantitative study of the biotransformation of insulin-enhancing VO2+ compounds , 2010, JBIC Journal of Biological Inorganic Chemistry.
[209] B. Stec,et al. A Model of the Transition State in the Alkaline Phosphatase Reaction* , 1999, The Journal of Biological Chemistry.
[210] Chasteen Nd,et al. Nonequivalence of the metal binding sites in vanadyl-labeled human serum transferrin. , 1975, Biochemistry.
[211] D. Manstein,et al. Crystal structure of human myosin 1c--the motor in GLUT4 exocytosis: implications for Ca2+ regulation and 14-3-3 binding. , 2014, Journal of molecular biology.
[212] J. Zuo,et al. Vanadium-iron-sulfur clusters containing the cubane-type [VFe3S4] core unit: synthesis of a cluster with the topology of the PN cluster of nitrogenase. , 2003, Inorganic chemistry.
[213] N. Chasteen,et al. An electron paramagnetic resonance study of vanadyl(IV)-serum albumin complexes , 1976 .
[214] D. Rehder. The Bioinorganic Chemistry of Vanadium , 1991 .
[215] A. Ferré-D’Amaré,et al. Transition State Stabilization by a Catalytic RNA , 2002, Science.
[216] J. K. Grady,et al. Characterization of the binding, kinetics, and redox stability of vanadium(IV) and vanadium(V) protein complexes in serum , 1986 .
[217] C. Geraldes,et al. Uptake and metabolic effects of insulin mimetic oxovanadium compounds in human erythrocytes. , 2005, Journal of inorganic biochemistry.
[218] Sohei Yamamoto,et al. Metal ion selectivity of the vanadium(V)-reductase Vanabin2. , 2013, Dalton transactions.
[219] N. Chasteen,et al. Metal ion complexes of apoferritin. Evidence for initial binding in the hydrophilic channels. , 1986, The Journal of biological chemistry.
[220] Michael Y. Galperin,et al. A superfamily of metalloenzymes unifies phosphopentomutase and cofactor‐independent phosphoglycerate mutase with alkaline phosphatases and sulfatases , 1998, Protein science : a publication of the Protein Society.
[221] H. Sakurai,et al. Specific binding of vanadyl ion (VO2+) with thiolate of the cysteine-34 residue in serum albumin, demonstrated by CD spectroscopy and kinetic property , 2003 .
[222] Bradley S. Moore,et al. A stereoselective vanadium-dependent chloroperoxidase in bacterial antibiotic biosynthesis. , 2011, Journal of the American Chemical Society.
[223] G. Micera,et al. Formation of new non-oxido vanadium(IV) species in aqueous solution and in the solid state by tridentate (O, N, O) ligands and rationalization of their EPR behavior. , 2013, Inorganic chemistry.
[224] R. F. Campbell,et al. An anion binding study of vanadyl(IV) human serotransferrin. Evidence for direct linkage to the metal. , 1977, The Journal of biological chemistry.
[225] W G Hol,et al. A model for the mechanism of human topoisomerase I. , 1998, Science.
[226] M. Mahroof-Tahir,et al. X-ray Structure of (NH4)6(Gly-Gly)2V10O28.cntdot.4H2O: Model Studies for Polyoxometalate-Protein Interactions , 1994 .
[227] P. Sadler,et al. Rationalisation of metal binding to transferrin: Prediction of metal-protein stability constants , 1997 .
[228] W. Casey,et al. Decavanadate, decaniobate, tungstate and molybdate interactions with sarcoplasmic reticulum Ca(2+)-ATPase: quercetin prevents cysteine oxidation by vanadate but does not reverse ATPase inhibition. , 2012, Dalton transactions.
[229] Clyde A. Smith,et al. Complexes of human lactoferrin with vanadium in oxidation states +3, +4 and +5 , 1995 .
[230] B. Sarkar,et al. Amino Terminal Cu(II)- and Ni(II)-Binding (ATCUN) Motif of Proteins and Peptides: Metal Binding, DNA Cleavage, and Other Properties† , 1997 .
[231] R. Brenk,et al. The small molecule tool (S)-(-)-blebbistatin: novel insights of relevance to myosin inhibitor design. , 2008, Organic & biomolecular chemistry.
[232] S. Robson,et al. Possible Effects of Microbial Ecto-Nucleoside Triphosphate Diphosphohydrolases on Host-Pathogen Interactions , 2008, Microbiology and Molecular Biology Reviews.
[233] P. Pedersen,et al. Novel Insights into the Chemical Mechanism of ATP Synthase , 1997, The Journal of Biological Chemistry.
[234] M. Zhou,et al. Overexpression, site-directed mutagenesis, and mechanism of Escherichia coli acid phosphatase. , 1992, The Journal of biological chemistry.
[235] R. Vanholder,et al. Fractionation of vanadium complexes in serum, packed cells and tissues of Wistar rats by means of gel filtration and anion-exchange chromatography , 2002, JBIC Journal of Biological Inorganic Chemistry.
[236] P. Sadler,et al. Interdomain zinc site on human albumin , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[237] J. Wedekind,et al. A comparison of vanadate to a 2'-5' linkage at the active site of a small ribozyme suggests a role for water in transition-state stabilization. , 2007, RNA.
[238] A. Tracey,et al. Interaction of vanadate with uridine and adenosine monophosphate. Formation of ADP and ATP analogs , 1988 .
[239] J. Champoux,et al. Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA. , 2000, Biochemistry.
[240] P. Sadler,et al. A new structural transition of serum albumin dependent on the state of Cys34. Detection by 1H-NMR spectroscopy. , 1994, European journal of biochemistry.
[241] J. Champoux,et al. RNase H activity: structure, specificity, and function in reverse transcription. , 2008, Virus research.
[242] A. Tracey. Hydroxamido vanadates: aqueous chemistry and function in protein tyrosine phosphatases and cell cultures. , 2000, Journal of inorganic biochemistry.
[243] D. Rees,et al. ABC transporters: the power to change , 2009, Nature Reviews Molecular Cell Biology.
[244] B. Gopal,et al. Conformational basis for substrate recognition and regulation of catalytic activity in Staphylococcus aureus nucleoside di-phosphate kinase. , 2011, Biochimica et biophysica acta.
[245] Chasteen Nd. Vanadium-protein interactions. , 1995 .
[246] A. Sanz-Medel,et al. Complementary FPLC-ICP-MS and MALDI-TOF for studying vanadium association to human serum proteins , 2005 .
[247] P. Dimroth,et al. Unique rotary ATP synthase and its biological diversity. , 2008, Annual review of biophysics.
[248] A. Saha,et al. Vanadate monomers and dimers both inhibit the human prostatic acid phosphatase. , 1989, Biochemical and biophysical research communications.
[249] D. Crans,et al. The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. , 2004, Chemical reviews.
[250] J. Sévigny,et al. The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance , 2006, Purinergic Signalling.
[251] Lisa A Lambert,et al. Evolution of duplications in the transferrin family of proteins. , 2005, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[252] A. Messerschmidt,et al. X-ray structures of apo and tungstate derivatives of vanadium chloroperoxidase from the fungus Curvularia inaequalis , 1998 .
[253] M. F. White,et al. Mechanistic implications for Escherichia coli cofactor-dependent phosphoglycerate mutase based on the high-resolution crystal structure of a vanadate complex. , 2002, Journal of molecular biology.
[254] J. Casey,et al. Vanadyl(IV) conalbumin. I. Metal binding site configurations , 1980 .
[255] R. Ramasamy,et al. Vanadate interactions with bovine copper,zinc-superoxide dismutase as probed by vanadium-51 NMR spectroscopy , 1991 .
[256] Romaidi,et al. Vanadium accumulation in ascidians : A system overview , 2015 .
[257] R. Eady. Current status of structure function relationships of vanadium nitrogenase , 2003 .
[258] D. Crans,et al. Interaction of trace levels of vanadium(IV) and vanadium(V) in biological systems , 1989 .
[259] M. Romão,et al. Interaction of vanadium(IV) with human serum apo-transferrin. , 2013, Journal of inorganic biochemistry.
[260] J. Champoux,et al. Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA, and a topoisomerase I-derived peptide. , 2003, Chemistry & biology.
[261] C. Trachsel,et al. Human Blood Plasma Proteins: Structure and Function , 2008 .
[262] V. Simplaceanu,et al. Assessment of roles of surface histidyl residues in the molecular basis of the Bohr effect and of beta 143 histidine in the binding of 2,3-bisphosphoglycerate in human normal adult hemoglobin. , 1999, Biochemistry.
[263] J. Moura,et al. Decavanadate interactions with actin: inhibition of G-actin polymerization and stabilization of decameric vanadate. , 2006, Journal of inorganic biochemistry.
[264] P J Sadler,et al. Transferrin as a metal ion mediator. , 1999, Chemical reviews.
[265] V. Pecoraro,et al. Modeling the biological chemistry of vanadium: Structural and reactivity studies elucidating biological function , 1997 .
[266] Ronald T. Raines,et al. Decavanadate inhibits catalysis by ribonuclease A. , 2000, Archives of biochemistry and biophysics.
[267] A. Tracey,et al. Vanadium: Chemistry, Biochemistry, Pharmacology and Practical Applications , 2007 .
[268] Zihua Hu,et al. Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin-induced diabetes. , 2011, Coordination chemistry reviews.
[269] S. Loubéry,et al. Membrane traffic in the secretory pathway , 2008, Cellular and Molecular Life Sciences.
[270] A. F. Neuwald. An unexpected structural relationship between integral membrane phosphatases and soluble haloperoxidases , 1997, Protein science : a publication of the Protein Society.
[271] Edward N. Baker,et al. Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins , 1990, Nature.
[272] G. Carman,et al. Identification of a novel phosphatase sequence motif , 1997, Protein science : a publication of the Protein Society.
[273] J. Sellers,et al. Mechanism of Blebbistatin Inhibition of Myosin II* , 2004, Journal of Biological Chemistry.
[274] J. K. Grady,et al. Vanadyl(IV) binding to mammalian ferritins. An EPR study aided by site-directed mutagenesis. , 2000, Journal of inorganic biochemistry.
[275] A. Wlodawer,et al. Active site of RNase: neutron diffraction study of a complex with uridine vanadate, a transition-state analog. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[276] Sean J. Johnson,et al. Impaired acid catalysis by mutation of a protein loop hinge residue in a YopH mutant revealed by crystal structures. , 2009, Journal of the American Chemical Society.
[277] M. W. Makinen,et al. The Structural Basis of Action of Vanadyl (VO2+) Chelates in Cells. , 2014, Coordination chemistry reviews.
[278] K. Thompson. Coordination chemistry of vanadium in metallopharmaceutical candidate compounds , 2001 .
[279] R. W. Collier. Particulate and dissolved vanadium in the North Pacific Ocean , 1984, Nature.
[280] S. Nair,et al. Structural and mechanistic insights into C-P bond hydrolysis by phosphonoacetate hydrolase. , 2011, Chemistry & biology.
[281] H. Vilter. Peroxidases from phaeophyceae: A vanadium(V)-dependent peroxidase from Ascophyllum nodosum , 1984 .
[282] G. George,et al. X-ray absorption of Azotobacter vinelandii vanadium nitrogenase , 1988 .
[283] J. Champoux,et al. Explorations of peptide and oligonucleotide binding sites of tyrosyl-DNA phosphodiesterase using vanadate complexes. , 2004, Journal of medicinal chemistry.
[284] A. Tracey,et al. The characterization of primary, secondary, and tertiary vanadate alkyl esters by 51V nuclear magnetic resonance spectroscopy , 1988 .
[285] G. Micera,et al. Complex formation in aqueous solution and in the solid state of the potent insulin-enhancing V(IV)O2+ compounds formed by picolinate and quinolinate derivatives. , 2011, Inorganic chemistry.
[286] K. Lau,et al. Phosphotyrosyl protein phosphatases. , 1989, The Biochemical journal.
[287] F. Bushman,et al. Insights from the structure of a smallpox virus topoisomerase-DNA transition state mimic. , 2010, Structure.
[288] G Schneider,et al. Crystal structures of rat acid phosphatase complexed with the transition-state analogs vanadate and molybdate. Implications for the reaction mechanism. , 1994, European journal of biochemistry.
[289] Kushol Gupta,et al. Requirements for catalysis in the Cre recombinase active site , 2010, Nucleic acids research.
[290] U Heinemann,et al. Three-dimensional structure of the ribonuclease T1 2'-GMP complex at 1.9-A resolution. , 1988, The Journal of biological chemistry.
[291] C. Orvig,et al. Design of vanadium compounds as insulin enhancing agents , 2000 .
[292] T. Otake,et al. Intracellular localization of vanadium in the fan worm Pseudopotamilla occelata , 1994 .
[293] I. Macara,et al. Accumulation of vanadium by tunicate blood cells occurs via a specific anion transport system , 1981 .
[294] M. Sebastián,et al. The alkaline phosphatase PhoX is more widely distributed in marine bacteria than the classical PhoA , 2009, The ISME Journal.
[295] Ting Xu,et al. Crystal Structure of the NS3 Protease-Helicase from Dengue Virus , 2007, Journal of Virology.
[296] L. Cantley,et al. Vanadate inhibits the red cell (Na+, K+) ATPase from the cytoplasmic side , 1978, Nature.
[297] P. Drake,et al. Peroxovanadium compounds: Biolgoical actions and mechanism of insulin-mimesis , 1995, Molecular and Cellular Biochemistry.
[298] I. Rayment,et al. The structural basis of blebbistatin inhibition and specificity for myosin II , 2005, Nature Structural &Molecular Biology.
[299] R. Wever,et al. Peroxidase and Phosphatase Activity of Active-site Mutants of Vanadium Chloroperoxidase from the Fungus Curvularia inaequalis , 2000, The Journal of Biological Chemistry.
[300] P. Hulley,et al. Regulation of tyrosine phosphorylation cascades by phosphatases: What the actions of vanadium teach us , 2003 .
[301] S. Phillips,et al. Sulphate ions observed in the 2.12 A structure of a new crystal form of S. cerevisiae phosphoglycerate mutase provide insights into understanding the catalytic mechanism. , 1999, Journal of molecular biology.
[302] G. Micera,et al. Interaction of VO2+ ion and some insulin-enhancing compounds with immunoglobulin G. , 2011, Inorganic chemistry.
[303] G. Micera,et al. Transport of the anti-diabetic VO2+ complexes formed by pyrone derivatives in the blood serum. , 2012, Journal of inorganic biochemistry.
[304] M. F. White,et al. High Resolution Structure of the Phosphohistidine-activated Form of Escherichia coli Cofactor-dependent Phosphoglycerate Mutase* , 2001, The Journal of Biological Chemistry.
[305] B. Künzli,et al. Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase‐3 , 2009, The FEBS journal.
[306] H. Sakurai,et al. Biospeciation of antidiabetic VO(IV) complexes , 2008 .
[307] Jue Chen,et al. Structural insights into ABC transporter mechanism. , 2008, Current opinion in structural biology.
[308] E. Westhof,et al. A three-dimensional model for the hammerhead ribozyme based on fluorescence measurements. , 1994, Science.
[309] A. Meden,et al. Synthesis and characterization of V(IV)O complexes of picolinate and pyrazine derivatives. Behavior in the solid state and aqueous solution and biotransformation in the presence of blood plasma proteins. , 2014, Inorganic chemistry.
[310] D. C. Harris. Different metal-binding properties of the two sites of human transferrin. , 1977, Biochemistry.
[311] A. Wlodawer,et al. Crystal Structures of the Semireduced and Inhibitor-bound Forms of Cyclic Nucleotide Phosphodiesterase from Arabidopsis thaliana * 210 , 2002, The Journal of Biological Chemistry.
[312] L. Cantley,et al. Glutathione reduces cytoplasmic vanadate. Mechanism and physiological implications. , 1980, Biochimica et biophysica acta.
[313] G. Micera,et al. Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin. , 2012, Dalton transactions.
[314] B. Sankaran,et al. P-glycoprotein Is Stably Inhibited by Vanadate-induced Trapping of Nucleotide at a Single Catalytic Site (*) , 1995, The Journal of Biological Chemistry.
[315] T. Drakenberg,et al. Cadmium(II), zinc(II), and copper(II) ions binding to bovine serum albumin. A 113Cd NMR study , 1982 .
[316] N. Chasteen,et al. A Q-band electron paramagnetic resonance study of vanadyl(IV)-labeled human serotransferrin , 1979 .
[317] T. Ueki,et al. Vanadium-binding protein in a vanadium-rich ascidian Ascidia sydneiensissamea: CW and pulsed EPR studies. , 2003, Journal of the American Chemical Society.
[318] M. Zhou,et al. Crystal structure of bovine low molecular weight phosphotyrosyl phosphatase complexed with the transition state analog vanadate. , 1997, Biochemistry.
[319] M. Wösten,et al. Functional analysis of a Campylobacter jejuni alkaline phosphatase secreted via the Tat export machinery. , 2008, Microbiology.
[320] P. Bevilacqua,et al. Nucleobase catalysis in ribozyme mechanism. , 2006, Current opinion in chemical biology.
[321] Francesco Luigi Gervasio,et al. DFT modeling of biological systems , 2006 .
[322] J. V. Van Beeumen,et al. Respiration and Growth of Shewanella oneidensis MR-1 Using Vanadate as the Sole Electron Acceptor , 2005, Journal of bacteriology.
[323] H. Sakurai,et al. Structural and redox requirements for the action of anti-diabetic vanadium compounds. , 2014, Dalton transactions.
[324] L. Prade,et al. Implications for the Catalytic Mechanism of the Vanadium-Containing Enzyme Chloroperoxidase from the Fungus Curvularia inaequalis by X-Ray Structures of the Native and Peroxide Form , 1997, Biological chemistry.
[325] H. Sakurai,et al. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV). , 1995, Biochemical and biophysical research communications.
[326] T. Whiteside,et al. Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer , 2009, Clinical Cancer Research.
[327] Anne Houdusse,et al. Structural and functional insights into the Myosin motor mechanism. , 2010, Annual review of biophysics.
[328] Miriam,et al. Recent advances in vanadium catalyzed oxygen transfer reactions , 2011 .
[329] P. Martel,et al. Binding modes of decavanadate to myosin and inhibition of the actomyosin ATPase activity. , 2007, Biochimica et biophysica acta.
[330] Elizabeth C. Theil,et al. Iron binding by horse spleen apoferritin. A vanadyl(IV) EPR spin probe study. , 1982, The Journal of biological chemistry.
[331] L. Beaugé. [23] Inhibition of translocation reactions by vanadate , 1988 .
[332] Somnath Roy,et al. New insights on vanadium binding to human serum transferrin , 2014 .
[333] B. Mikami,et al. Crystal structure of diferric hen ovotransferrin at 2.4 A resolution. , 1995, Journal of molecular biology.
[334] T. Kiss,et al. Binding of Oxovanadium(IV) Complexes to Blood Serum Albumins , 2017 .
[335] J. Aaseth,et al. The effect of chelating agents on vanadium distribution in the rat body and on uptake by human erythrocytes , 1982, Archives of Toxicology.
[336] A. Salifoglou,et al. The chemistry and biology of vanadium compounds in cancer therapeutics , 2015 .
[337] V. Pecoraro,et al. Assessing the dependence of (51)V A(z) value on the aromatic ring orientation of V(IV)O(2+) pyridine complexes. , 2009, Inorganic chemistry.
[338] T. Ueki,et al. High Levels of Vanadium in Ascidians , 2012 .
[339] J. Poznański,et al. Spectroscopic and thermodynamic determination of three distinct binding sites for Co(II) ions in human serum albumin. , 2009, Journal of inorganic biochemistry.
[340] S. Everse,et al. The Crystal Structure of Iron-free Human Serum Transferrin Provides Insight into Inter-lobe Communication and Receptor Binding* , 2006, Journal of Biological Chemistry.
[341] S. Eaton,et al. Comparison of the electron spin echo envelope modulation (ESEEM) for human lactoferrin and transferrin complexes of copper(II) and vanadyl ion. , 1989, The Journal of biological chemistry.
[342] L. Pedersen,et al. The Sulfuryl Transfer Mechanism , 1998, The Journal of Biological Chemistry.
[343] A. Butler,et al. Vanadium-51 NMR as a probe of vanadium(V) coorination to human apotransferrin , 1989 .
[344] G. Micera,et al. New developments in the comprehension of the biotransformation and transport of insulin-enhancing vanadium compounds in the blood serum. , 2010, Inorganic chemistry.
[345] L. F. Hass,et al. 2,3-diphosphoglycerate phosphatase activity of phosphoglycerate mutase: stimulation by vanadate and phosphate. , 1987, Biochemistry.
[346] G. Willsky,et al. Is vanadate reduced by thiols under biological conditions? Changing the redox potential of V(V)/V(IV) by complexation in aqueous solution. , 2010, Inorganic chemistry.
[347] D. Crans,et al. Vanadate tetramer as the inhibiting species in enzyme reactions in vitro and in vivo , 1990 .
[348] M. Aureliano. Vanadate oligomer inhibition of passive and active Ca2+ translocation by the Ca2+ pump of sarcoplasmic reticulum. , 2000, Journal of inorganic biochemistry.
[349] D. Barford,et al. Crystal structure of human protein tyrosine phosphatase 1B. , 1994, Science.
[350] D. Rehder. The potentiality of vanadium in medicinal applications. , 2012, Future medicinal chemistry.
[351] Haiwei Luo,et al. Subcellular localization of marine bacterial alkaline phosphatases , 2009, Proceedings of the National Academy of Sciences.
[352] M. F. White,et al. The two analogous phosphoglycerate mutases of Escherichia coli , 1999, FEBS letters.
[353] K. Gekko,et al. Characterization of vanadium-binding sites of the vanadium-binding protein Vanabin2 by site-directed mutagenesis. , 2009, Biochimica et biophysica acta.
[354] J. Pessoa,et al. Transport of therapeutic vanadium and ruthenium complexes by blood plasma components. , 2010, Current medicinal chemistry.
[355] J. Krahn,et al. Structure of an Aprataxin–DNA complex with insights into AOA1 Neurodegenerative Disease , 2011, Nature Structural &Molecular Biology.
[356] Subhash G. Vasudevan,et al. Crystal Structure of the Dengue Virus RNA-Dependent RNA Polymerase Catalytic Domain at 1.85-Angstrom Resolution , 2007, Journal of Virology.
[357] N. Sträter,et al. Crystallographic evidence for a domain motion in rat nucleoside triphosphate diphosphohydrolase (NTPDase) 1. , 2012, Journal of molecular biology.
[358] P. Holliger,et al. Ribozyme-Catalyzed Transcription of an Active Ribozyme , 2011, Science.
[359] T. Kuzuyama,et al. Characterization of the fomA andfomB Gene Products from Streptomyces wedmorensis, Which Confer Fosfomycin Resistance on Escherichia coli , 2000, Antimicrobial Agents and Chemotherapy.
[360] K. Locher,et al. Structure of AMP-PNP-bound vitamin B12 transporter BtuCD–F , 2012, Nature.
[361] Wei Yang,et al. Stepwise analyses of metal ions in RNase H catalysis from substrate destabilization to product release , 2006, The EMBO journal.
[362] A. Knowles. The GDA1_CD39 superfamily: NTPDases with diverse functions , 2011, Purinergic Signalling.
[363] Arieh Warshel,et al. Why nature really chose phosphate , 2013, Quarterly Reviews of Biophysics.
[364] M. Aureliano,et al. Interactions of vanadate oligomers with sarcoplasmic reticulum Ca(2+)-ATPase. , 1994, Biochimica et biophysica acta.
[365] U. Heinemann,et al. Crystal structure of guanosine-free ribonuclease T1, complexed with vanadate (V), suggests conformational change upon substrate binding. , 1989, Biochemistry.
[366] Y. Asano,et al. X‐ray structures of a novel acid phosphatase from Escherichia blattae and its complex with the transition‐state analog molybdate , 2000, The EMBO journal.
[367] P. Harrison,et al. The ferritins: molecular properties, iron storage function and cellular regulation. , 1996, Biochimica et biophysica acta.
[368] I. Lamont,et al. Crystal structures of Escherichia coli uridine phosphorylase in two native and three complexed forms reveal basis of substrate specificity, induced conformational changes and influence of potassium. , 2004, Journal of molecular biology.
[369] J. Tanner,et al. Structure of Francisella tularensis AcpA , 2006, Journal of Biological Chemistry.
[370] K. Locher,et al. Asymmetric states of vitamin B12 transporter BtuCD are not discriminated by its cognate substrate binding protein BtuF , 2012, FEBS letters.
[371] H. Sweeney,et al. The Structural Basis for the Large Powerstroke of Myosin VI , 2007, Cell.
[372] M. Vieth,et al. Kinomics-structural biology and chemogenomics of kinase inhibitors and targets. , 2004, Biochimica et biophysica acta.
[373] D. Barrio,et al. Interactions of vanadyl(IV) with dithiothreitol and thioglycolic acid. Their action on alkaline phosphatase activity , 1999 .
[374] K. Locher,et al. Asymmetry in the Structure of the ABC Transporter-Binding Protein Complex BtuCD-BtuF , 2007, Science.
[375] D. Rehder. The future of/for vanadium. , 2013, Dalton transactions.
[376] D. Manstein,et al. Mechanism and Specificity of Pentachloropseudilin-mediated Inhibition of Myosin Motor Activity , 2011, The Journal of Biological Chemistry.
[377] D. Barrio,et al. On the interaction of the vanadyl(IV) cation with lactose , 2007, Biological Trace Element Research.
[378] H. Tajmir-Riahi,et al. Interaction of human serum albumin with oxovanadium ions studied by FT-IR spectroscopy and gel and capillary electrophoresis , 2001 .
[379] T. Kiss,et al. The systems VIVO2+-glutathione and related ligands: a potentiometric and spectroscopic study , 2002, JBIC Journal of Biological Inorganic Chemistry.
[380] J. Sowadski,et al. Refined structure of alkaline phosphatase from Escherichia coli at 2.8 A resolution. , 1985, Journal of molecular biology.
[381] N. Sträter,et al. Cellular function and molecular structure of ecto-nucleotidases , 2012, Purinergic Signalling.
[382] B. Annabi,et al. Transmembrane Topology of Glucose-6-Phosphatase* , 1998, The Journal of Biological Chemistry.
[383] Daniele Sanna,et al. Interaction of insulin-enhancing vanadium compounds with human serum holo-transferrin. , 2013, Inorganic chemistry.
[384] D. Rehder,et al. The medicinal and catalytic potential of model complexes of vanadate-dependent haloperoxidases , 2003 .
[385] L. Josephson,et al. Isolation of a potent (Na-K)ATPase inhibitor from striated muscle. , 1977, Biochemistry.
[386] J. McMurray,et al. A1 H spin echo and 51V NMR study of the interaction of vanadate with intact erythrocytes , 1997, JBIC Journal of Biological Inorganic Chemistry.
[387] C. Post,et al. The oxyvanadium constellation in transition-state-analogue complexes of phosphoglucomutase and ribonuclease. Structural deductions from electron-transfer spectra. , 1990, Biochemistry.
[388] J. G. Kuenen,et al. New enzyme belonging to the family of molybdenum-free nitrate reductases. , 2003, The Biochemical journal.
[389] H. Dekker,et al. From phosphatases to vanadium peroxidases: a similar architecture of the active site. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[390] C. Haynes,et al. Calorimetric studies of the interaction between the insulin-enhancing drug candidate bis(maltolato)oxovanadium(IV) (BMOV) and human serum apo-transferrin. , 2009, Journal of inorganic biochemistry.
[391] M. Aureliano,et al. Ion pumps as biological targets for decavanadate. , 2013, Dalton transactions.
[392] Joseph Bertolini,et al. Transferrin: structure, function and potential therapeutic actions. , 2005, Drug discovery today.
[393] H. Sakurai,et al. Speciation of insulin-mimetic VO(IV)-containing drugs in blood serum. , 2000, Journal of inorganic biochemistry.
[394] Arata Yoji,et al. Mn2+-probe ESR method for the analyses of the dissociation of charged residues on the surface of immunoglobulins. , 1986 .
[395] Geoffrey Chang,et al. Flexibility in the ABC transporter MsbA: Alternating access with a twist , 2007, Proceedings of the National Academy of Sciences.
[396] Jue Chen,et al. Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems , 2008, Microbiology and Molecular Biology Reviews.
[397] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[398] L. Delage,et al. The Vanadium Iodoperoxidase from the Marine Flavobacteriaceae Species Zobellia galactanivorans Reveals Novel Molecular and Evolutionary Features of Halide Specificity in the Vanadium Haloperoxidase Enzyme Family , 2014, Applied and Environmental Microbiology.
[399] Chasteen Nd,et al. Metal site conformational states of vanadyl(IV) human serotransferrin complexes. , 1977 .
[400] N. Kelleher,et al. Heterologous production of fosfomycin and identification of the minimal biosynthetic gene cluster. , 2006, Chemistry & biology.
[401] L M Amzel,et al. The 2.8-A structure of rat liver F1-ATPase: configuration of a critical intermediate in ATP synthesis/hydrolysis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[402] C. Supuran,et al. ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme. , 2007, Chemical communications.
[403] J. Moura,et al. Decavanadate as a biochemical tool in the elucidation of muscle contraction regulation. , 2004, Journal of inorganic biochemistry.
[404] C. Goodno. Inhibition of myosin ATPase by vanadate ion. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[405] D. Barford,et al. Visualization of the Cysteinyl-phosphate Intermediate of a Protein-tyrosine Phosphatase by X-ray Crystallography* , 1998, The Journal of Biological Chemistry.
[406] S. Buchanan,et al. A structural comparison of human serum transferrin and human lactoferrin , 2007, BioMetals.
[407] Decavanadate binding to a high affinity site near the myosin catalytic centre inhibits F-actin-stimulated myosin ATPase activity. , 2004 .
[408] W. Filipowicz,et al. Cloning and Characterization of the ArabidopsisCyclic Phosphodiesterase Which Hydrolyzes ADP-ribose 1",2"-Cyclic Phosphate and Nucleoside 2′,3′-Cyclic Phosphates* , 1997, The Journal of Biological Chemistry.
[409] Jue Chen,et al. Snapshots of the maltose transporter during ATP hydrolysis , 2011, Proceedings of the National Academy of Sciences.
[410] B. Akabayov,et al. Vanadate in structural biology , 2014 .
[411] T. R. Gilbert,et al. Vanadium and other metal ions in the physiological ecology of marine organisms , 1983 .
[412] A. Messerschmidt,et al. X-ray structure of a vanadium-containing enzyme: chloroperoxidase from the fungus Curvularia inaequalis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[413] J. H. Viles,et al. 1H and (113)Cd NMR Investigations of Cd(2+) and Zn(2+) Binding Sites on Serum Albumin: Competition with Ca(2+), Ni(2+), Cu(2+), and Zn(2+). , 1996, Inorganic chemistry.
[414] M. Battell,et al. Vanadium compounds as insulin mimics. , 1999, Metal ions in biological systems.
[415] A. Ferré-D’Amaré,et al. Crystal structure of a hairpin ribozyme–inhibitor complex with implications for catalysis , 2001, Nature.
[416] Clive R. Bagshaw,et al. Insights into the Importance of Hydrogen Bonding in the γ-Phosphate Binding Pocket of Myosin: Structural and Functional Studies of Serine 236†,‡ , 2010, Biochemistry.
[417] L. Josephson,et al. A characterization of vanadate interactions with the (Na,K)-ATPase. Mechanistic and regulatory implications. , 1978, The Journal of biological chemistry.
[418] D. Fattorini,et al. Hyperaccumulation of vanadium in the Antarctic polychaete Perkinsiana littoralis as a natural chemical defense against predation , 2010, Environmental science and pollution research international.
[419] J. Casey,et al. Vanadyl(IV) conalbumin. II. Mixed metal and anion binding studies , 1980 .
[420] A. Wlodawer,et al. Structure and mechanism of activity of the cyclic phosphodiesterase of Appr>p, a product of the tRNA splicing reaction , 2000, The EMBO journal.
[421] M. Kollmar,et al. Crystal structure of the motor domain of a class‐I myosin , 2002, The EMBO journal.
[422] G. Grüber,et al. Nucleotide binding states of subunit A of the A-ATP synthase and the implication of P-loop switch in evolution. , 2010, Journal of molecular biology.
[423] T. Kiss,et al. Vanadate complexes in serum: a speciation modeling study. , 2010, Dalton transactions.
[424] A. N. Antipov,et al. Vanadium‐Binding Protein Excreted by Vanadate‐Reducing Bacteria , 2000, IUBMB life.
[425] Z. Zhang,et al. Protein-tyrosine phosphatases: biological function, structural characteristics, and mechanism of catalysis. , 1998, Critical reviews in biochemistry and molecular biology.
[426] Gonçalo J. L. Bernardes,et al. CORM-3 reactivity toward proteins: the crystal structure of a Ru(II) dicarbonyl-lysozyme complex. , 2011, Journal of the American Chemical Society.
[427] R. Lancashire,et al. Oxovanadium(IV) and amino acids—I. The system L-alanine+VO2+ ; a potentiometric and spectroscopic study , 1988 .
[428] A. Davidson,et al. Vanadate-Induced Trapping of Nucleotides by Purified Maltose Transport Complex Requires ATP Hydrolysis , 2000, Journal of bacteriology.
[429] R. Warner,et al. Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle. , 1977, The Journal of biological chemistry.
[430] G. Micera,et al. On the transport of vanadium in blood serum. , 2009, Inorganic chemistry.
[431] B. Sankaran,et al. Both P-glycoprotein Nucleotide-binding Sites Are Catalytically Active (*) , 1995, The Journal of Biological Chemistry.
[432] H. Yoshida,et al. The ribonuclease T1 family. , 2001, Methods in enzymology.
[433] G. Micera,et al. Application of DFT Methods in the Study of VIVO2+ -Peptide Interactions , 2010 .
[434] S. Piersma,et al. Cofactor and substrate binding to vanadium chloroperoxidase determined by UV-VIS spectroscopy and evidence for high affinity for pervanadate. , 2000, Biochemistry.
[435] K. Kustin,et al. Do vanadate polyanions inhibit phosphotransferase enzymes? , 1985, Biochimica et biophysica acta.
[436] D. Rees,et al. Nitrogenase MoFe-Protein at 1.16 Å Resolution: A Central Ligand in the FeMo-Cofactor , 2002, Science.
[437] J. Tawara,et al. A kinetic method for determination of free vanadium(IV) and (V) at trace level concentrations. , 1990, Analytical biochemistry.
[438] H. Sakurai,et al. Detection of vanadyl‐nitrogen interaction in organs of the vanadyl‐treated rat: electron spin echo envelope modulation study , 1995, FEBS letters.
[439] Edmond Lam,et al. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals. , 2005, Journal of the American Chemical Society.
[440] G. Chaconas,et al. The circle is broken: telomere resolution in linear replicons. , 2001, Current opinion in microbiology.
[441] M. V. Nogués,et al. Bovine pancreatic ribonuclease: fifty years of the first enzymatic reaction mechanism. , 2011, Biochemistry.
[442] E. Jankowsky,et al. RNA helicases--one fold for many functions. , 2007, Current opinion in structural biology.
[443] J. Champoux,et al. The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA. , 2006, Journal of molecular biology.
[444] T. Kiss,et al. The system VO2+ +oxidized glutathione: a potentiometric and spectroscopic study. , 2001, Journal of inorganic biochemistry.
[445] Robert J.P. Williams,et al. The Chemistry of Evolution: The Development of our Ecosystem , 2005 .
[446] H. R. Evans,et al. C3 exoenzyme from Clostridium botulinum: structure of a tetragonal crystal form and a reassessment of NAD-induced flexure. , 2004, Acta crystallographica. Section D, Biological crystallography.